Shanmuga Hospital Limited has informed the stock exchanges about an upcoming board meeting scheduled for May 11, 2026, to approve its audited financial results for the quarter and year ended March 31, 2026. The announcement was made through a formal intimation to BSE Limited on April 30, 2026.

Board Meeting Details

The board meeting will be conducted at the company's registered office located at 51/24 Saradha College Road, Salem - 636 007. The meeting has been scheduled in accordance with Regulation 29(1)(a) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Meeting Agenda

The board will primarily focus on considering and approving the audited financial results for the fourth quarter and full year ended March 31, 2026. Additionally, the agenda includes provision for any other business matters that may be taken up with the permission of the chairperson.

Trading Window Closure

In compliance with insider trading regulations, Shanmuga Hospital Limited has implemented a trading window closure for dealing in the company's securities. The trading window has been closed with effect from April 1, 2026, and will continue to remain closed until 48 hours after the declaration of the audited financial results.

Corporate Communication

The intimation was signed by Kannan Anjana Maragatham, Company Secretary & Compliance Officer, who holds membership number A70080. The communication was digitally signed and submitted to ensure proper regulatory compliance and transparency with stakeholders.

Shanmuga Hospital Limited has submitted its mandatory quarterly compliance certificate to BSE Limited, fulfilling regulatory requirements under SEBI's depositories framework. The certificate covers the period from January 1, 2026, to March 31, 2026, representing the first quarter of calendar year 2026.

Regulatory Compliance Filing

The company filed the certificate on April 9, 2026, in accordance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018. This regulation mandates listed companies to provide periodic confirmations regarding share transfer activities through their designated registrar and transfer agents.

Share Transfer Activity Report

Integrated Registry Management Services Private Limited, serving as the company's Registrar and Share Transfer Agent, confirmed zero activity during the reporting period. The RTA specifically stated that no requests for dematerialisation or rematerialisation of shares were received between January 1, 2026, and March 31, 2026.

Corporate Governance Framework

The filing demonstrates the company's adherence to SEBI's corporate governance requirements for listed entities. Kannan Anjana Maragatham, Company Secretary and Compliance Officer with membership number A70080, signed the submission on behalf of Shanmuga Hospital Limited.

S Giridhar, General Manager at Integrated Registry Management Services Private Limited, authenticated the RTA certificate with digital signatures, ensuring compliance with electronic filing norms. The systematic reporting reflects the company's commitment to maintaining transparent shareholder records and regulatory compliance standards.